| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 23 |
| 1 | METHOTREXATE SODIUM | 17 |
| 2 | MYCOPHENOLATE MOFETIL | 17 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 17 |
| 4 | METHOTREXATE | 15 |
| 5 | TACROLIMUS | 13 |
| 6 | PREDNISOLONE | 10 |
| 7 | PREDNISOLONE ORAL | 10 |
| 8 | PREDNISOLONE ORAL SOLUTION | 10 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MENTHOL, METHYL SALICYLATE | 1 | 0.0017 |
| 1 | CEFTAROLINE FOSAMIL | 1 | 0.0012 |
| 2 | REVUMENIB | 1 | 0.0010 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 7 | 0.0008 |
| 4 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0006 |
| 5 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 6 | AMPHETAMINE SULFATE TABLETS | 1 | 0.0006 |
| 7 | BRODALUMAB | 1 | 0.0005 |
| 8 | ETEPLIRSEN | 1 | 0.0004 |
| 9 | VALGANCICLOVIR | 7 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 45 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 15 |
| 4 | Loop Diuretic [EPC] | 9 |
| 5 | Glycopeptide Antibacterial [EPC] | 7 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 7 |
| 7 | Thalidomide Analog [EPC] | 7 |
| 8 | Vitamin C [EPC] | 7 |
| 9 | Azole Antifungal [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 3 | Alkaloid [EPC] | 5 | 0.0002 |
| 4 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 5 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 6 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 7 | Glycopeptide Antibacterial [EPC] | 7 | 0.0001 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Anti-anginal [EPC] | 1 | 0.0001 |